Since 2012, the Columbia Biomedical Technology Accelerator has been helping teams of Columbia physicians, engineers, and natural scientists turn their biomedical inventions into lifesaving commercial products.
Now the incubator, also known as BiomedX, has received a boost from Yiannis Monovoukas ’84SEAS. A prominent biotechnology executive, Monovoukas has donated $1 million to create a fund, named for him and his wife, Jamie, that will provide financial backing and support services to promising ventures in BiomedX’s pipeline.
“BiomedX combines my passions for innovation, engineering, and entrepreneurship,” says Monovoukas, the former chairman, president, and CEO of TEI Biosciences, a regenerative-medicine company, and a member of the engineering school’s Board of Visitors.
